Brief: Tongfang Kontafarma Says Unit Received Court Summons In Relation To Claim Made By Shanghai Haixin Pharmaceutical Co
30/03/2021 16:14
March 30 (Reuters) - Tongfang Kontafarma Holdings Ltd
1312.HK :
* UNIT RECEIVED COURT SUMMONS IN RELATION TO CLAIM MADE BY
SHANGHAI HAIXIN PHARMACEUTICAL CO
* PLAINTIFF SEEKS FOR COURT ORDER TO TERMINATE COOPERATION
AGREEMENT, AND CLAIMS AGAINST UNIT FOR DAMAGES OF RMB49 MILLION
Source text for Eikon: ID:nHKS8C8ZL6
Further company coverage: 1312.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr